Brief: Cyclerion Therapeutics Announces Global Licensing Agreement With Akebia Therapeutics For Praliciguat

Korsana Biosciences

04/06/2021 13:27

June 4 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS ANNOUNCES GLOBAL LICENSING
AGREEMENT WITH
AKEBIA THERAPEUTICS FOR PRALICIGUAT
    * CYCLERION - ELIGIBLE TO RECEIVE UP TO $585 MILLION IN
POTENTIAL
FUTURE DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS, AND TIERED
SALES-BASED ROYALTIES
    * CYCLERION - UNDER AGREEMENT, AKEBIA HAS OBTAINED AN
EXCLUSIVE
LICENSE TO RESEARCH, DEVELOP AND COMMERCIALIZE PRALICIGUAT
GLOBALLY

Source text for Eikon:  ID:nGNX7Nrt5g 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))